
Avenir Life Science Private Limited
About Avenir Life Science Private Limited
Data last updated:
Avenir Life Science Private Limited is a private limited company based in Uttranchal, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24232UR2005PTC030650. Its GSTIN is 05AAHCA6195N1Z6 (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.8 Lakh. It is led by directors including Rajneesh Goel and Shubham Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 128 Krishan Nagar Ext Dehradun, Uttranchal, Uttarakhand, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹79.16 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹45,603 (net margin 0.6%) and EBITDA of ₹6.55 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 91% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Avenir Life Science Private Limited's registered office is in Uttranchal, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address128 Krishan Nagar Ext Dehradun, Uttranchal, Uttarakhand, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avenir Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avenir Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avenir Life Science Private Limited, buy the company report.
Financials of Avenir Life Science Private Limited
FY 2025 filings availableAvenir Life Science Private Limited reported revenue of ₹79.16 Lakh (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 91%. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45,603 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avenir Life Science Private Limited, buy the company report.
Board of directors of Avenir Life Science Private Limited
Avenir Life Science has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajneesh Goel Also directs: Technica Labs & Pharma Private Limited | Director | 19 Sep 2005 | 21 Years 1 Months | Current |
| Shubham Goel | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
| Seema Goel Also directs: Technica Labs & Pharma Private Limited | Director | 19 Sep 2005 | 21 Years 1 Months | Current |
Peer comparison
Avenir Life Science Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asian Pharmaceuticals Private Limited | ₹79.44 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| Avenir Life Science Private Limitedthis company | ₹79.16 Lakh (FY 2025) | ₹45,603 | 0.6% | -28.0% | Uttranchal, Uttarakhand, India | |
| Orange Nutraceutical Private Limited | ₹79 Lakh (FY 2025) | -76.0% | Gandhinagar, Gujarat, India | |||
| Synergy Biopharma P Ltd | ₹78.84 Lakh (FY 2025) | -12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Avenir Life Science Private Limited, buy the company report.
Auditor
Avenir Life Science Private Limited is audited by PAWANKUMARGUPTA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWANKUMARGUPTA | FY 2022 | 077516 |
Shareholding
The shareholding of Avenir Life Science Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avenir Life Science Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Oct 2023 | 100812283 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Avenir Life Science Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Manishkumar Amrutlal Shah Proprietor Ms Kahan Pharmaceuticals | Disposed |
To see the full case history of Avenir Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avenir Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avenir Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCA6195N1Z6 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avenir Life Science Private Limited, buy the company report.
Recent activity
Avenir Life Science Private Limited has 4 board changes on record since 2005: 3 appointments and 1 cessation. The latest: Shubham Goel ceased to be Additional Director on 30 Sep 2018.
Frequently asked questions
Avenir Life Science is an active private limited company based in Uttranchal, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2005 (21+ years old) and is registered under CIN U24232UR2005PTC030650.
Avenir Life Science has 3 current directors:
- Rajneesh Goel - Director
- Shubham Goel - Director
- Seema Goel - Director
The latest financial statements of Avenir Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avenir Life Science is 05AAHCA6195N1Z6, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Avenir Life Science is U24232UR2005PTC030650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avenir Life Science has 1 court case on record: 1 filed against it.
Avenir Life Science was incorporated on 19 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Avenir Life Science by revenue are Asian Pharmaceuticals Private Limited, Orange Nutraceutical Private Limited, Synergy Biopharma P Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shubham Goel ceased to be Additional Director on 30 Sep 2018. Shubham Goel was appointed as Director on 21 Sep 2018. Rajneesh Goel was appointed as Director on 19 Sep 2005. Avenir Life Science has 4 board changes on record in total.
The registered office of Avenir Life Science is at 128 Krishan Nagar Ext Dehradun, Uttranchal, Uttarakhand, India.
Avenir Life Science operates in the pharma industry, in the drug formulation and development segment.

